Research output per year
Research output per year
Personal profile
Research interests
I am interested in looking at biobehavioral influences on ovarian cancer progression and treatment. Also I am a clinical principal investigator in the Endometrial SPORE project at Washington University. Additonally, I am involved in multiple clinical trials for various gynecologic cancers.
Clinical interests
Gynecologic oncology, endometrial cancer, vulvar carcinoma, cervical cancer, ovarian cancer, adnexal masses, tumors, hysterectomy, ob/gyn, women's health, lymphadenectomy, endometrial adenocarcinomas, cervical intraepithelial neoplasia, laparoscopy, gynecologic malignancies
Fingerprint
Dive into the research topics where Premal Thaker is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283
O'Cearbhaill, R. E., Miller, A., Soslow, R. A., Lankes, H. A., DeLair, D., Segura, S., Chavan, S., Zamarin, D., DeBernardo, R., Moore, K., Moroney, J., Shahin, M., Thaker, P. H., Wahner-Hendrickson, A. E. & Aghajanian, C., Sep 2023, In: Gynecologic oncology. 176, p. 16-24 9 p.Research output: Contribution to journal › Article › peer-review
-
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer
Holloway, R. W., Thaker, P., Mendivil, A. A., Ahmad, S., Al-Niaimi, A. N., Barter, J., Beck, T., Chambers, S. K., Coleman, R. L., Crafton, S. M., Crane, E., Ramez, E., Ghamande, S., Graybill, W., Herzog, T., Indermaur, M. D., John, V. S., Landrum, L., Lim, P. C., Lucci, J. A., & 12 others, Sep 1 2023, In: International Journal of Gynecological Cancer. 33, 9, p. 1458-1463 6 p.Research output: Contribution to journal › Article › peer-review
-
Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 “Lynch-like” mismatch repair gene mutation
Toboni, M. D., Wu, S., Farrell, A., Xiu, J., Ribeiro, J. R., Oberley, M. J., Arend, R., Erickson, B. K., Herzog, T. J., Thaker, P. H. & Powell, M. A., Oct 2023, In: Gynecologic oncology. 177, p. 132-141 10 p.Research output: Contribution to journal › Article › peer-review
-
Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival
Kotnik, E. N., Mullen, M. M., Spies, N. C., Li, T., Inkman, M., Zhang, J., Martins-Rodrigues, F., Hagemann, I. S., McCourt, C. K., Thaker, P. H., Hagemann, A. R., Powell, M. A., Mutch, D. G., Khabele, D., Longmore, G. D., Mardis, E. R., Maher, C. A., Miller, C. A. & Fuh, K. C., Dec 2023, In: Communications Biology. 6, 1, 688.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosis
Bruce, S. F., Wu, S., Ribeiro, J. R., Farrell, A., Oberley, M. J., Winer, I., Erickson, B. K., Klc, T., Jones, N. L., Thaker, P. H. & Powell, M. A., May 2023, In: Gynecologic oncology. 172, p. 98-105 8 p.Research output: Contribution to journal › Article › peer-review